Home Compare EMG.L vs PFE
Stock Comparison · Structural lead, mixed market

Man Group vs Pfizer: Which Stock Looks Stronger in 2026?

Man holds the cleaner structural position, with profitability as the main driver and valuation adding further support. Pfizer still has the edge on valuation, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across profitability and growth, rather than sitting in one isolated gap. The overall score gap is 8 points in favour of Man Group Plc.

Trajectory Similarity
0.65
Moderately similar
Peer-set rank: #2
within Man Group Plc's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

Most of the shared profile comes through recent revenue growth and investment intensity.

Similarity drivers
recent revenue growthinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
EMG.L
Man Group Plc
50
Peer-Score
Signal qualityMedium
vs
PFE
Pfizer Inc.
42
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: EMG.L vs PFE Profitability 40 12 Stability 67 48 Valuation 55 82 Growth 40 19 EMG.L PFE
Gap Ranking
#1 Profitability +28
#2 Valuation +27
#3 Growth +21
#4 Stability +19
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EMG.L and PFE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EMG.LPFE Relative valuation Structural strength

Man Group Plc still looks stronger overall, though current pricing looks more supportive for Pfizer Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Man Group Plc sits higher in the group on profitability, adding to the overall structural advantage.
Valuation
Both rank well on valuation, but Pfizer Inc. still holds a clear edge.
Profitability — Dominant Gap
EMG.L
40
PFE
12
Gap+28in favour of EMG.L

Capital efficiency adds support, with a 9-point ROIC advantage.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Pfizer, with a trailing P/E that is 3.4 turns lower there.

What this means for the comparison

Profitability is the clearest driver of the lead, with valuation adding further support — though valuation still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the EMG.L vs PFE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how EMG.L and PFE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.